Orano Med Revenue and Competitors
Estimated Revenue & Valuation
- Orano Med's estimated annual revenue is currently $18.3M per year.
- Orano Med's estimated revenue per employee is $155,000
Employee Data
- Orano Med has 118 Employees.
- Orano Med grew their employee count by 12% last year.
Orano Med's People
| Name | Title | Email/Phone |
|---|
Orano Med Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Orano Med?
Based on an R&D program started in 2005 by our founder, Patrick Bourdet, Orano Med has developed new processes for producing high-purity lead-212, a rare radioactive isotope. Lead-212 is currently at the heart of promising research projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.
keywords:N/A
N/A
Total Funding
118
Number of Employees
$18.3M
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Plano
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $20.3M | 118 | 11% | N/A |
#2 | $11.8M | 118 | 46% | N/A |
#3 | $32.4M | 120 | 8% | N/A |
#4 | $25.2M | 120 | 9% | N/A |
#5 | $30.5M | 120 | 5% | N/A |